BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AngioDynamics (ANGO) Pledges $500,000 to Society Of Interventional Radiology


4/3/2013 10:28:23 AM

Gift supports SIRF's Discovery Campaign to expand minimally invasive medicine

FAIRFAX, Va., April 2, 2013 /PRNewswire-USNewswire/ -- The Society of Interventional Radiology Foundation's Discovery campaign will benefit from a $500,000 pledge by new "Futurist" level supporter, medical device manufacturer AngioDynamics.

"Initiatives of this kind continue to reinforce opportunities for investment in the specialty's future, with funding that supports grants, research consensus panels, registries, clinical trials and educational programming," said John A. Kaufman, M.D., FSIR, chair of the SIR Foundation board of directors. "Our specialty's hallmarks are investigation and innovation, and the impact that major corporate support has on the future of the specialty is transformational," noted Kaufman, who is also a professor and Frederick S. Keller Chair of Interventional Radiology at the Dotter Interventional Institute in Portland, Ore.

"AngioDynamics has always shared the SIR Foundation's passion for fueling innovation in patient care through research and education. Our company is committed to being a partner in patient care with interventional radiologists through our support of the SIR Foundation and its pursuit of new discoveries in minimally invasive treatments," said Joseph DeVivo, Angiodynamics' president and chief executive officer. "This Discovery Campaign commitment underscores our long-time dedication to interventional radiologists and to advancing the treatment of millions of patients worldwide," he added.

The Discovery Campaign was launched initially in 2007 with an SIR membership phase. In 2010, the campaign began outreach to the medical technology industry for support. For information about the Society of Interventional Radiology, a national organization of nearly 4,700 doctors, scientists and allied health professionals dedicated to improving health care through minimally invasive treatments, visit online at www.SIRweb.org. For more information about the Discovery Campaign or to learn more about the Society of Interventional Radiology Foundation, visit online at www.SIRFoundation.org.

About the Society of Interventional Radiology Foundation

SIR Foundation is a scientific foundation dedicated to fostering research and education in interventional radiology for the purposes of advancing scientific knowledge, increasing the number of skilled investigators in interventional radiology and developing innovative therapies that lead to improved patient care and quality of life. Visit SIR Foundation.org.

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.

Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. Visit www.SIRweb.org.

About AngioDynamics

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

Trademarks

AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

SOURCE Society of Interventional Radiology Foundation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES